Logo image of SPTN

SPARTANNASH CO (SPTN) Stock Fundamental Analysis

NASDAQ:SPTN - Nasdaq - US8472151005 - Common Stock

17.72  -0.53 (-2.9%)

Fundamental Rating

4

Taking everything into account, SPTN scores 4 out of 10 in our fundamental rating. SPTN was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of SPTN get a neutral evaluation. Nothing too spectacular is happening here. SPTN is valued correctly, but it does not seem to be growing. SPTN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SPTN was profitable.
In the past year SPTN had a positive cash flow from operations.
SPTN had positive earnings in each of the past 5 years.
SPTN had a positive operating cash flow in each of the past 5 years.
SPTN Yearly Net Income VS EBIT VS OCF VS FCFSPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

1.2 Ratios

SPTN's Return On Assets of 1.84% is in line compared to the rest of the industry. SPTN outperforms 42.50% of its industry peers.
With a Return On Equity value of 5.81%, SPTN perfoms like the industry average, outperforming 42.50% of the companies in the same industry.
The Return On Invested Capital of SPTN (5.65%) is comparable to the rest of the industry.
SPTN had an Average Return On Invested Capital over the past 3 years of 4.31%. This is below the industry average of 8.38%.
The 3 year average ROIC (4.31%) for SPTN is below the current ROIC(5.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.84%
ROE 5.81%
ROIC 5.65%
ROA(3y)2.32%
ROA(5y)2.09%
ROE(3y)6.79%
ROE(5y)6.25%
ROIC(3y)4.31%
ROIC(5y)4.39%
SPTN Yearly ROA, ROE, ROICSPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin of SPTN (0.48%) is worse than 60.00% of its industry peers.
SPTN's Profit Margin has improved in the last couple of years.
SPTN has a Operating Margin (1.41%) which is comparable to the rest of the industry.
SPTN's Operating Margin has declined in the last couple of years.
SPTN's Gross Margin of 15.60% is on the low side compared to the rest of the industry. SPTN is outperformed by 80.00% of its industry peers.
SPTN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.41%
PM (TTM) 0.48%
GM 15.6%
OM growth 3Y-3.4%
OM growth 5Y-2.63%
PM growth 3Y-12.37%
PM growth 5Y5.55%
GM growth 3Y0.06%
GM growth 5Y2.09%
SPTN Yearly Profit, Operating, Gross MarginsSPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPTN is destroying value.
SPTN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPTN has less shares outstanding
Compared to 1 year ago, SPTN has a worse debt to assets ratio.
SPTN Yearly Shares OutstandingSPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
SPTN Yearly Total Debt VS Total AssetsSPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

SPTN has an Altman-Z score of 4.66. This indicates that SPTN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.66, SPTN is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
A Debt/Equity ratio of 0.80 indicates that SPTN is somewhat dependend on debt financing.
SPTN has a worse Debt to Equity ratio (0.80) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Altman-Z 4.66
ROIC/WACC0.75
WACC7.56%
SPTN Yearly LT Debt VS Equity VS FCFSPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

SPTN has a Current Ratio of 1.62. This is a normal value and indicates that SPTN is financially healthy and should not expect problems in meeting its short term obligations.
SPTN has a better Current ratio (1.62) than 77.50% of its industry peers.
SPTN has a Quick Ratio of 1.62. This is a bad value and indicates that SPTN is not financially healthy enough and could expect problems in meeting its short term obligations.
SPTN has a Quick ratio of 0.83. This is in the better half of the industry: SPTN outperforms 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.83
SPTN Yearly Current Assets VS Current LiabilitesSPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

SPTN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.58%.
Measured over the past 5 years, SPTN shows a small growth in Earnings Per Share. The EPS has been growing by 3.12% on average per year.
The Revenue has decreased by -2.66% in the past year.
The Revenue has been growing slightly by 3.82% on average over the past years.
EPS 1Y (TTM)-7.58%
EPS 3Y-4.84%
EPS 5Y3.12%
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y1.34%
Revenue growth 5Y3.82%
Sales Q2Q%-0.6%

3.2 Future

The Earnings Per Share is expected to decrease by -4.27% on average over the next years.
The Revenue is expected to grow by 0.08% on average over the next years.
EPS Next Y-10.52%
EPS Next 2Y-4.97%
EPS Next 3Y-4.27%
EPS Next 5YN/A
Revenue Next Year-2.24%
Revenue Next 2Y-0.07%
Revenue Next 3Y0.08%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPTN Yearly Revenue VS EstimatesSPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
SPTN Yearly EPS VS EstimatesSPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.09 indicates a reasonable valuation of SPTN.
Based on the Price/Earnings ratio, SPTN is valued cheaper than 92.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of SPTN to the average of the S&P500 Index (28.29), we can say SPTN is valued rather cheaply.
SPTN is valuated reasonably with a Price/Forward Earnings ratio of 9.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SPTN indicates a rather cheap valuation: SPTN is cheaper than 90.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. SPTN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.09
Fwd PE 9
SPTN Price Earnings VS Forward Price EarningsSPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPTN is valued cheaply inside the industry as 82.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.23
SPTN Per share dataSPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

A cheap valuation may be justified as SPTN's earnings are expected to decrease with -4.27% in the coming years.
PEG (NY)N/A
PEG (5Y)2.92
EPS Next 2Y-4.97%
EPS Next 3Y-4.27%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.78%, SPTN is a good candidate for dividend investing.
SPTN's Dividend Yield is rather good when compared to the industry average which is at 2.47. SPTN pays more dividend than 97.50% of the companies in the same industry.
SPTN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 4.78%

5.2 History

On average, the dividend of SPTN grows each year by 9.50%, which is quite nice.
SPTN has been paying a dividend for at least 10 years, so it has a reliable track record.
SPTN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.5%
Div Incr Years13
Div Non Decr Years17
SPTN Yearly Dividends per shareSPTN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

65.83% of the earnings are spent on dividend by SPTN. This is not a sustainable payout ratio.
SPTN's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP65.83%
EPS Next 2Y-4.97%
EPS Next 3Y-4.27%
SPTN Yearly Income VS Free CF VS DividendSPTN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M
SPTN Dividend Payout.SPTN Dividend Payout, showing the Payout Ratio.SPTN Dividend Payout.PayoutRetained Earnings

SPARTANNASH CO

NASDAQ:SPTN (1/22/2025, 2:52:30 PM)

17.72

-0.53 (-2.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners86.44%
Inst Owner Change-0.97%
Ins Owners1.34%
Ins Owner Change0%
Market Cap598.05M
Analysts76.36
Price Target22.78 (28.56%)
Short Float %2.98%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield 4.78%
Yearly Dividend0.85
Dividend Growth(5Y)9.5%
DP65.83%
Div Incr Years13
Div Non Decr Years17
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-1.96%
Max EPS beat(2)2.38%
EPS beat(4)2
Avg EPS beat(4)-2%
Min EPS beat(4)-10.29%
Max EPS beat(4)2.38%
EPS beat(8)2
Avg EPS beat(8)-4.49%
EPS beat(12)5
Avg EPS beat(12)-0.81%
EPS beat(16)7
Avg EPS beat(16)-0.23%
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-3.6%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-2.84%
Min Revenue beat(4)-3.6%
Max Revenue beat(4)-1.29%
Revenue beat(8)1
Avg Revenue beat(8)-2.71%
Revenue beat(12)4
Avg Revenue beat(12)-1.37%
Revenue beat(16)4
Avg Revenue beat(16)-1.36%
PT rev (1m)0%
PT rev (3m)-1.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 9.09
Fwd PE 9
P/S 0.06
P/FCF N/A
P/OCF 5.12
P/B 0.77
P/tB 1.22
EV/EBITDA 5.23
EPS(TTM)1.95
EY11%
EPS(NY)1.97
Fwd EY11.11%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)3.46
OCFY19.54%
SpS282.46
BVpS23.15
TBVpS14.5
PEG (NY)N/A
PEG (5Y)2.92
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 5.81%
ROCE 7.63%
ROIC 5.65%
ROICexc 5.7%
ROICexgc 6.84%
OM 1.41%
PM (TTM) 0.48%
GM 15.6%
FCFM N/A
ROA(3y)2.32%
ROA(5y)2.09%
ROE(3y)6.79%
ROE(5y)6.25%
ROIC(3y)4.31%
ROIC(5y)4.39%
ROICexc(3y)4.36%
ROICexc(5y)4.44%
ROICexgc(3y)5.32%
ROICexgc(5y)5.47%
ROCE(3y)5.82%
ROCE(5y)5.93%
ROICexcg growth 3Y-5.08%
ROICexcg growth 5Y-3.41%
ROICexc growth 3Y-4.29%
ROICexc growth 5Y-1.45%
OM growth 3Y-3.4%
OM growth 5Y-2.63%
PM growth 3Y-12.37%
PM growth 5Y5.55%
GM growth 3Y0.06%
GM growth 5Y2.09%
F-Score7
Asset Turnover3.86
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF N/A
Debt/EBITDA 2.65
Cap/Depr 129.94%
Cap/Sales 1.38%
Interest Coverage 3.17
Cash Conversion 49.47%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 0.83
Altman-Z 4.66
F-Score7
WACC7.56%
ROIC/WACC0.75
Cap/Depr(3y)103.65%
Cap/Depr(5y)93.67%
Cap/Sales(3y)1.04%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.58%
EPS 3Y-4.84%
EPS 5Y3.12%
EPS Q2Q%-11.11%
EPS Next Y-10.52%
EPS Next 2Y-4.97%
EPS Next 3Y-4.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y1.34%
Revenue growth 5Y3.82%
Sales Q2Q%-0.6%
Revenue Next Year-2.24%
Revenue Next 2Y-0.07%
Revenue Next 3Y0.08%
Revenue Next 5YN/A
EBIT growth 1Y41.75%
EBIT growth 3Y-2.11%
EBIT growth 5Y1.09%
EBIT Next Year84.27%
EBIT Next 3Y24.65%
EBIT Next 5YN/A
FCF growth 1Y77.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y373.21%
OCF growth 3Y-33.71%
OCF growth 5Y-12.22%